Find a Provider

Anthony R. Mato, MD

Anthony R. Mato, MD Physician

Assistant Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Mato is a Penn Medicine employed physician.

Clinical Specialties

Specialties:

  • Medicine
    • Hematology
    • Medical Oncology

Programs & Services:

  • Cancer
    • Bone Marrow Transplant and Stem Cell Transplant Program
    • Leukemia
  • Hematology-Oncology
    • Classical (Non-Malignant) Hematology Program

Board Certification:

  • Hematology, 2008
  • Internal Medicine, 2005
  • Medical Oncology, 2008

Conditions & Treatments:

  • Blood Cancer
  • chronic lymphocytic leukemia
  • Hodgkin's lymphoma
  • Lymphoma
  • non-Hodgkin's lymphoma

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Care
  • Rail Road Medicare / Palmetto GBA
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: State University of New York at Buffalo
Residency: Hospital of the University of Pennsylvania
Fellowship: Hospital of the University of Pennsylvania

Memberships

American College of Physician Executives, National American Society of Clinical Oncology, National American Society of Hematology, National

Affiliation

Dr. Mato is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Mato Anthony R, Foon Kenneth A, Feldman Tatyana, Schuster Stephen J, Svoboda Jakub, Chow Kar Fai, Valentinetti Marisa, Mrkulic Mary, Azzollini Kelly, Gadaleta Gabriella, Bhattacharyya Pritish K, Zenreich Joshua, Pascual Lauren-Nicole, Yannotti Kara, Kdiry Sabrina, Howlett Christina, Strelec Lauren, Porter David, Bejot Coleen, Goy André: Reduced-dose fludarabine, cyclophosphamide, and rituximab (FCR-Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia. American Journal of Hematology 90 (6): 487-92,2015.

Vesole David H, Bilotti Elizabeth, Richter Joshua R, McNeill Ann, McBride Laura, Raucci Laura, Anand Palka, Bednarz Urszula, Ivanovski Kristin, Smith Judith, Batra Veena, Aleman Adolfo, Sims Taliah, Guerrero Laura, Mato Anthony, Siegel David S: Phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in patients with relapsed and/or refractory multiple myeloma. British Journal of Haematology : 2015.

Chong Elise A, Ahmadi Tahamtan, Aqui Nicole A, Svoboda Jakub, Nasta Sunita D, Mato Anthony R, Walsh Kristy M, Schuster Stephen J: Combination of Lenalidomide and Rituximab Overcomes Rituximab Resistance in Patients with Indolent B-cell and Mantle Cell Lymphomas. Clinical Cancer Research 21 (8): 1835-42,2015.

Academic Contact Info

3400 Civic Center Blvd
2 PCAM West

Philadelphia, PA 19146
Phone: (215) 615-3251
Fax: (215) 662-4064
Patient appointments: 800-789-PENN (7366)

Related Links